| Christina Leon, | |
|
400 Sullivan Rd, Aurora, IL 60506-1452 | |
| (630) 859-3700 | |
| Not Available |
| Full Name | Christina Leon |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 400 Sullivan Rd, Aurora, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285196469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 056.012877 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christina Leon, 400 Sullivan Rd, Aurora, IL 60506-1452 Ph: () - | Christina Leon, 400 Sullivan Rd, Aurora, IL 60506-1452 Ph: (630) 859-3700 |
News Archive
Frequent measurement of blood flow changes could improve the ability of health care providers to diagnose and treat patients with vascular conditions, such as those associated with diabetes and high blood pressure.
Orexigen((R)) Therapeutics, Inc. today announced that Mark Booth has joined the Company as Chief Commercial Officer. Mr. Booth brings over 25 years of commercial and business development experience to Orexigen. Most recently he served as President of Takeda Pharmaceuticals North America (TPNA) where he presided over the commercial, medical and scientific affairs, business development and all support functions.
Author Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in this Foreign Policy opinion piece that the announcement researchers from the Netherlands and the U.S. have developed a supercontagious variety of bird flu "has highlighted a dilemma: How do you balance the universal mandate for scientific openness against the fear that terrorists or rogue states might follow the researchers' work - using it as catastrophic cookbooks for global influenza contagion?"
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of primary peritoneal cancers.
› Verified 9 days ago
Alejandra Mayte Castellanos, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4020 E New York St, Aurora, IL 60504 Phone: 331-301-5590 | |
Zoe Monks, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 N Commons Dr Ste 102, Aurora, IL 60504 Phone: 708-478-1820 | |
Ryan Driessens, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1599 N Farnsworth Ave, Aurora, IL 60505 Phone: 630-585-5901 | |
Candace Attaway, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3403 Ravinia Cir, Aurora, IL 60504 Phone: 815-272-1027 | |
Ms. Misty E Ayers-cumbow, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1245 Corporate Blvd Ste 101, Aurora, IL 60505 Phone: 630-898-2200 Fax: 630-898-5555 | |
Alison Humbird, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2073 Conway Ln, Aurora, IL 60503 Phone: 630-333-8628 | |
Ariana J. Galvan, MOT, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 773-319-9576 |